A customer in the united states reported a false negative (no growth) for a staphylococcus aureus cap survey organism in association with the chromid® (b)(6) agar (udi (b)(4)).An investigation was performed.A review of quality records confirmed there were no discrepancies with the manufacturing of the lot number.Testing was performed on the biomérieux retained samples of the customer lot and a reference lot.Inoculation of the retained samples followed the qc method with qc strains.In parallel, a batch of gts media was used for control.The following results were obtained : good growth of pink colonies for the (b)(6) strain tested (s.Aureus atcc 43300) after 24 hours of incubation on both customer and reference lots of chromid (b)(6).Total inhibition for the (b)(6) strains tested (s.Aureus 0504605, s.Aureus 0506614, s.Aureus atcc 29213) after 24 hours of incubation and 48 hours for the atcc strain.Total inhibition for e.Coli atcc 8739 and c.Albicans atcc 10231 after 48 hour of incubation.Partial inhibition for e.Faecalis atcc 29212 after 48hours of incubation.All results conformed with specifications for the media and were equivalent between both lots tested.The instructions for use, challenge testing section states, "a challenge set composed of 80 meca (b)(6) strains and 5 mecc (b)(6) strains was inoculated on the chromid (b)(6) medium with an inoculum equivalent to 103 cfu/ml.After 24 hours of incubation, the following results were observed.58/80 (72.5%) of meca (b)(6) strains and 4/5 (80%) of mecc (b)(6) strains were detected on the chromid (b)(6) medium." thus we assume that certain strains of (b)(6) can not be detected.The investigation did not reproduce the issue observed by the customer on the retained samples.Without return of customer isolate, it is not possible to continue the investigation.
|